Advocacy intelligence hub — real-time data for patient organizations
Nantes University Hospital
Alimera Sciences — PHASE4
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
HUMIRA
(adalimumab)Orphan drugstandardAbbVie, Inc.
12.1 Mechanism of Action Adalimumab binds specifically to TNF-alpha and blocks its interaction with the p55 and p75 cell surface TNF receptors. Adalim...
Laurence Bouillet, Professor
Grenoble Hospital University
📍 Grenoble
Yan Li, PhD
Oregon Health and Science University
Thomas Ciulla, MD, M.D
Clearside Biomedical, Inc.
📍 CARMEL, IN
John D. Sheppard, M.D.
Study Principal Investigator
Quan D Nguyen, MD, MSc
Johns Hopkins University
Quan D Nguyen, MD MSc
Ocular Imaging Research and Reading Center